Analysis of Hospitalizations for COPD Exacerbation: Opportunities for Improving Care

REFERENCES

• Celli BR. Chronic obstructive pulmonary disease: From unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc 2006; 3:58–65.
   PubMedGoogle Scholar
• Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4:502–506.
   PubMedGoogle Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51:1–16.
   PubMed Web of Science ®Google Scholar
• Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: Final data for 2003. Natl Vital Stat Rep 2006;54:1–120.
   PubMedGoogle Scholar
• Bach PB, Brown C, Gelfand SE, McCrory DC. Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence. Ann Intern Med 2001;134:600–620.
   PubMed Web of Science ®Google Scholar
• Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1980; 93:391–398.
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council working party. Lancet 1981; 1:681–686.
   PubMed Web of Science ®Google Scholar
• Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials. Am J Med 2002; 113:59–65.
   PubMed Web of Science ®Google Scholar
• Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial. BMJ 2000; 320:1297–1303.
   PubMed Web of Science ®Google Scholar
• Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial. Lancet 2003; 361:449–456.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775–789.
   PubMed Web of Science ®Google Scholar
• Jones PW, Willits LR, Burge PS, Calverley PM. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003; 21:68–73.
   PubMed Web of Science ®Google Scholar
• Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:144–149.
   PubMed Web of Science ®Google Scholar
• Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA, Jr., Korducki L, Cassino C, Kesten S. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial. Ann Intern Med 2005; 143:317–326.
   PubMed Web of Science ®Google Scholar
• Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, Fishman AP. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial research group. Ann Thorac Surg 2006; 82:431–443.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999; 115:957–965.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T. Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:1084–1091.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, Knobil K. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130:647–656.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059–2073.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
   PubMed Web of Science ®Google Scholar
• Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001; 134:595–599.
   PubMed Web of Science ®Google Scholar
• Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Bratzler D, Oehlert W, McAdams L, Leon J, Jiang H, Piatt D. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: Physician practices in the community hospital setting. J Okla State Med Assoc 2004;97:227–232.
   PubMedGoogle Scholar
• Mularski R, Asch S, Shrank W, Kerr E, Setodji C, Adams J, Keesey J, McGlynn E. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 2006; 130:1844–1850.
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2006; 144:894–903.
   PubMed Web of Science ®Google Scholar
• Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282:1458–1465.
   PubMed Web of Science ®Google Scholar
• Glaab T, Banik N, Rutschmann OT, Wencker M. National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD 2006; 3:141–148.
   PubMedGoogle Scholar
• Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP. Knowledge of guidelines for the management of COPD: A survey of primary care physicians. Respir Med 2004; 98:932–937.
   PubMed Web of Science ®Google Scholar
• Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725–2732.
   PubMed Web of Science ®Google Scholar
• Peach H, Pathy MS. Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis. Thorax 1981; 36:585–589.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608–1613.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847–852.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418–1422.
   PubMed Web of Science ®Google Scholar
• McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007; 132:1748–1755.
   PubMed Web of Science ®Google Scholar
• Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163:1180–1186.
   PubMed Web of Science ®Google Scholar
• Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM. UK national COPD audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006; 61:837–842.
   PubMed Web of Science ®Google Scholar
• Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274:1852–1857.
   PubMed Web of Science ®Google Scholar
• Connors AF, Jr., Dawson NV, Thomas C, Harrell FE, Jr., Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 1996; 154:959–967.
   PubMed Web of Science ®Google Scholar
• Anthonisen N, Connett J, Kiley J, Altose M, Bailey W, Buist A, Conway WJ, Enright P, Kanner R, O’Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health study. JAMA 1994; 272:1497–1505.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial. Ann Intern Med 2005; 142:233–239.
   PubMed Web of Science ®Google Scholar
• Freund M, Campbell E, Paul C, McElduff P, Walsh R, Sakrouge R, Wiggers J, Knight J. Smoking care provision in hospitals: A review of prevalence. Nicotine Tob Res 2008; 10:757–774.
   PubMed Web of Science ®Google Scholar
• Houston T, Allison J, Person S, Kovac S, Williams O, Kiefe C. Post-myocardial infarction smoking cessation counseling: Associations with immediate and late mortality in older medicare patients. Am J Med 2005; 118:269–275.
   PubMed Web of Science ®Google Scholar
• Lee T, Weaver F, Weiss K. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 2007; 22:62–67.
   PubMed Web of Science ®Google Scholar
• Nichol K, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437–2442.
   PubMed Web of Science ®Google Scholar
• Petersen R, Saag K, Wallace R, Doebbeling B. Influenza and pneumococcal vaccine receipt in older persons with chronic disease: A population-based study. Med Care 1999; 37:502– 509.
   PubMed Web of Science ®Google Scholar
• Granger R, Walters J, Poole PJ, Lasserson TJ, Mangtani P, Cates CJ, Wood-Baker R. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006: CD001390.
   PubMed Web of Science ®Google Scholar
• Nichol K. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med 1998; 105:385–392.
   PubMed Web of Science ®Google Scholar
• Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543– 1554.
   PubMed Web of Science ®Google Scholar
• Sidney S, Sorel M, Quesenberry CP, Jr., DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program. Chest 2005; 128:2068–2075.
   PubMed Web of Science ®Google Scholar
• Barr R, Celli B, Mannino D, Petty T, Rennard S, Sciurba F, Stoller J, Thomashow B, GM T. Comorbidities in a national sample of chronic obstructive pulmonary disease. Amer J Med 2009; 122:348–355.
   PubMed Web of Science ®Google Scholar